The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Alzheimer’s Disease: Epidemiology and Clinical Progression
Open accessAbstract
Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The diseases encompass various severe conditions, including neurodegenerative disorders like Alzheimer’s disease (AD) [3, 4] and Parkinson’s disease (PD) [5, 6], as well as traumatic brain injuries (TBI) [7] and spinal cord injuries (SCI) [8].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 2×
“4% of all deaths attributable to dementia in 2016 [31].”
Background
Cited by
Sorted by citations
Safiri, S., Jolfayi, A. G., Fazlollahi, A., Morsali, S., Sarkesh, A., Sorkhabi, A. D., Golabi, B., Aletaha, R., Asghari, K. M., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 273
Di Benedetto, G., Burgaletto, C., Bellanca, C. M., Munafò, A., Bernardini, R., & Cantarella, G. (2022) · Cells · doi:10.3390/cells11172728 · Cited by 189
Vrahatis, A. G., Skolariki, K., Krokidis, M. G., Lazaros, K., Exarchos, T. P., & Vlamos, P. (2023) · Sensors · doi:10.3390/s23094184 · Cited by 184
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Sivamaruthi, B. S., Raghani, N. R., Chorawala, M. R., Bhattacharya, S., Prajapati, B. G., Elossaily, G. M., & Chaiyasut, C. (2023) · Biomedicines · doi:10.3390/biomedicines11092587 · Cited by 126
Pless, A., Ware, D., Saggu, S., Rehman, H., Morgan, J., & Wang, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1263771 · Cited by 131
Lecanemab Treatment in a Specialty Memory Clinic
Paczynski, M., Hofmann, A., Posey, Z. J., Gregersen, M., Rudman, M., Ellington, D., Aldinger, M., Musiek, E. S., Holtzman, D. M., Bateman, R. J., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1232 · Cited by 116
Oxidative Stress, Endoplasmic Reticulum Stress and Apoptosis in the Pathology of Alzheimer’s Disease
Ekundayo, B. E., Obafemi, T. O., Adewale, O. B., Obafemi, B. A., Oyinloye, B. E., & Ekundayo, S. K. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01248-2 · Cited by 110
Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes
Dolotov, O. V., Inozemtseva, L. S., Myasoedov, N. F., & Grivennikov, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094999 · Cited by 104
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Pradeepkiran, J. A., Baig, J., Islam, M. A., Kshirsagar, S., & Reddy, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0286 · Cited by 87
Formolo, D. A., Yu, J., Lin, K., Tsang, H. W. H., Ou, H., Kranz, G. S., & Yau, S. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00618-3 · Cited by 70
Pei, J., Kumarasamy, R. V., Jayaraman, S., Kanniappan, G. V., Long, Q., & Palanisamy, C. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102665 · Cited by 72
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Dias, D., & Socodato, R. (2025) · Biomedicines · doi:10.3390/biomedicines13020279 · Cited by 60
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56
Potential therapeutic use of plant flavonoids in AD and PD
Meng-zhen, S., Ju, L., Zhang, L., Cai-feng, D., Shu-da, Y., Hao-fei, Y., & Wei-yan, H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11440 · Cited by 56
Antioxidant Potential of Lactoferrin and Its Protective Effect on Health: An Overview
Rascón-Cruz, Q., Siqueiros-Cendón, T., Siañez-Estrada, L. I., Villaseñor-Rivera, C. M., Ángel-Lerma, L. E., Olivas-Espino, J. A., León-Flores, D. B., Espinoza-Sánchez, E. A., Arévalo‐Gallegos, S., & Iglesias-Figueroa, B. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010125 · Cited by 55
Gao, J., Liu, J., Xu, Y., Peng, D., & Wang, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1222751 · Cited by 51
Astara, K., Tsimpolis, A., Kalafatakis, K., Vavougios, G. D., Xiromerisiou, G., Dardiotis, E., Christodoulou, G. N., Samara, M. T., & Lappas, A. S. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111899 · Cited by 50
Acharya, M. R., Deo, R. C., Barua, P. D., Devi, A., & Tao, X. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108652 · Cited by 46
Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Sree, R. R., Kalyan, M., Anand, N., Mani, S., Gorantla, V. R., Sakharkar, M. K., Song, B., & Chidambaram, S. B. (2025) · ACS Omega · doi:10.1021/acsomega.4c05527 · Cited by 45
Extracellular vesicle therapy in neurological disorders
Putthanbut, N., Lee, J.-Y., & Borlongan, C. V. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01075-w · Cited by 44
Gogna, T., Housden, B. E., & Houldsworth, A. (2024) · Antioxidants · doi:10.3390/antiox13091138 · Cited by 47
The ROSMAP project: aging and neurodegenerative diseases through omic sciences
Pérez-González, A. P., García-Kroepfly, A. L., Pérez-Fuentes, K. A., García-Reyes, R. I., Solis-Roldan, F. F., Alba-González, J. A., Lemus, E. H., & de Anda‐Jáuregui, G. (2024) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2024.1443865 · Cited by 49
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Ren, Y., Pieper, A. A., & Cheng, F. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00553 · Cited by 48
Munteanu, C., Galaction, A., Turnea, M. A., Blendea, C. D., Rotariu, M., & Poştaru, M. (2024) · Antioxidants · doi:10.3390/antiox13091062 · Cited by 43
Costanzo, M., Cutrona, C., Leodori, G., Malimpensa, L., D’Antonio, F., Conte, A., & Belvisi, D. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01607-4 · Cited by 40
Zhang, Y., Tang, C., He, Y., Zhang, Y., Li, Q., Zhang, T., Zhao, B., Tong, A., Zhong, Q., & Zhong, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117540 · Cited by 36
PET brain imaging in neurological disorders
Xie, L., Zhao, J., Li, Y., & Bai, J. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.03.007 · Cited by 38
Advances in nanomaterials based laser desorption/ionization mass spectrometry for metabolic analysis
Yang, C., Ji, S., Shen, S., Yu, H., & Deng, C. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118190 · Cited by 36
Jarek, D. J., Mizerka, H., Nuszkiewicz, J., & Szewczyk‐Golec, K. (2024) · Biomedicines · doi:10.3390/biomedicines12040786 · Cited by 37
Sleep disorders and risk of alzheimer's disease: A two-way road
Lacerda, R. A. V., Desio, J. A. F., Kammers, C. M., Henkes, S. F. C., de Sá, M. F., de Souza, E. F., da Silva, D. M., Gusmão, C. T. P., & dos Santos, J. C. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102514 · Cited by 36
Association between body mass index and cognitive impairment in Chinese older adults
Dong, W., Kan, L., Zhang, X., Li, M., Wang, M., & Cao, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1255101 · Cited by 34
New horizons in the diagnosis and management of Alzheimer’s Disease in older adults
Dolphin, H., Dyer, A. H., Morrison, L., Shenkin, S. D., Welsh, T. J., & Kennelly, S. (2024) · Age and Ageing · doi:10.1093/ageing/afae005 · Cited by 33
Bandara, E. M. S., Asih, P. R., Pedrini, S., Hone, E., Fernando, W. M. A. D. B., & Martins, R. N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05219-3 · Cited by 37
Endocytosis and Alzheimer’s disease
Zadka, Ł., Sochocka, M., Hachiya, N., Chojdak-Łukasiewicz, J., Dzięgiel, P., Piasecki, E., & Leszek, J. (2023) · GeroScience · doi:10.1007/s11357-023-00923-1 · Cited by 33
Roth, S., Burnie, N., Suridjan, I., Yan, J. T., & Carboni, M. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr230007 · Cited by 32
Harnessing the potential of mesenchymal stem cells–derived exosomes in degenerative diseases
Liao, H., Yang, Y., Liu, Y., Tseng, H., Huo, T., Chiou, S., & Chang, C.-H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.08.001 · Cited by 32
Metabolic stress and age drive inflammation and cognitive decline in mice and humans
Elzinga, S. E., Guo, K., Turfah, A., Henn, R. E., Webber‐Davis, I. F., Hayes, J. M., Pacut, C. M., Teener, S. J., Carter, A., Rigan, D. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70060 · Cited by 35
Sugandhi, V. V., Gadhave, D. G., Ugale, A. R., Kulkarni, N. N., Nangare, S., Patil, H. P., Rath, S., Saxena, R., Lavate, A., Patel, A. T., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102775 · Cited by 32
Harris, G. A., Hirschfeld, L. R., González, M. I., Pritchard, M. C., & May, P. C. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01775-x · Cited by 31
Antonioni, A., Martorana, A., Santarnecchi, E., Hampel, H. J., & Koch, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70337 · Cited by 31
Xu, J., Gao, C., Zhang, J., Lu, J., Xuan, Y., Wang, S., & Bu, C. (2025) · Molecular Imaging · doi:10.1177/15353508251393056 · Cited by 31
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 30
Bashir, S., Aiman, A., Shahid, M., Chaudhary, A. A., Sami, N., Basir, S. F., Hassan, M. I., & Islam, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102276 · Cited by 31
Use of Wearable Sensors to Assess Fall Risk in Neurological Disorders: Systematic Review
Bonanno, M., Ielo, A., Pasquale, P. D., Celesti, A., Nunzio, A. M. D., Quartarone, A., & Calabrò, R. S. (2025) · JMIR mhealth and uhealth · doi:10.2196/67265 · Cited by 30
Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
Scarano, N., Musumeci, F., Casini, B., Brullo, C., D’Ursi, P., Fossa, P., Schenone, S., & Cichero, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146980 · Cited by 32
Zhang, J., Hao, J., Liu, R., Wu, T., Liu, R., Sui, W., & Zhang, M. (2022) · Food & Function · doi:10.1039/d2fo02871a · Cited by 30
Jahanshahi, A., Sadeh, R. N., & Khezerloo, D. (2023) · Experimental Brain Research · doi:10.1007/s00221-022-06543-z · Cited by 30
Plaza-Rosales, I., Brunetti, E. P., Montefusco‐Siegmund, R., Madariaga, S., Hafelin, R., Ponce, D. P., Behrens, M. I., Maldonado, P., & Paula-Lima, A. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1097577 · Cited by 30
SERS-Based Optical Nanobiosensors for the Detection of Alzheimer’s Disease
Gao, F., Li, F., Wang, J., Yu, H., Li, X., Chen, H., Wang, J., Qin, D., Li, Y., Liu, S., et al. (2023) · Biosensors · doi:10.3390/bios13090880 · Cited by 31
Dantas, J. M., Mutarelli², A. M., Navalha, D. D. P., Dagostin, C. S., Romeiro, P. H. C. L., Felix, N. S., Nogueira, A., Batista, S., Teixeira, L., & Caramelli, P. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07194-w · Cited by 29
Soleimani, H., Dehghani, S., Abolli, S., Alamdari, H. A., Gheisvandi, O., Atlasi, R., Yazdi, N. B., Tabatabaei‐Malazy, O., Soleimani, Z., & Handy, R. D. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118759 · Cited by 29
Damluji, A. A., Nanna, M. G., Mason, P., Lowenstern, A. M., Orkaby, A. R., Washam, J. B., Kolkailah, A. A., Beckie, T. M., Dangas, G., & Lawton, J. S. (2025) · Circulation · doi:10.1161/cir.0000000000001387 · Cited by 30
Meca, A.-D., Boboc, I. K. Ş., Mititelu-Tarțău, L., & Bogdán, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060354 · Cited by 29
Antonioni, A., Raho, E. M., Lorenzo, F. D., Manzoli, L., Flacco, M. E., & Koch, G. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12996-3 · Cited by 34
Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review
Abubakar, M., Giri, A., Goel, F., Khan, M., Gupta, J., Kumar, D., Kaushik, M., Nand, S., & Kumar, N. (2025) · Current Neuropharmacology · doi:10.2174/011570159x384737250626094315 · Cited by 29
Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment
Deng, C., Chen, H., Meng, Z., & Meng, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.955618 · Cited by 28
Functional connectivity changes in mild cognitive impairment: A meta-analysis of M/EEG studies
Buzi, G., Fornari, C., Perinelli, A., & Mazza, V. (2023) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.10.011 · Cited by 29
Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy
Cipriano, G. L., Mazzon, E., & Anchesi, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169077 · Cited by 27
Muhammad, A., Qi, J., Elwasila, O., & Gulzar, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15060612 · Cited by 33
Elgazar, A. A., El-Domany, R. A., Eldehna, W. M., & Badria, F. A.-E. (2023) · RSC Advances · doi:10.1039/d3ra04867e · Cited by 27
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil
Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Abdel‐Fattah, M. M., Alsaiari, A. A., Alruwaili, M., Papadakis, M., Alexiou, A. T., & Batiha, G. E. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01554-0 · Cited by 26
Song, H., Liu, J., Wang, L., Hu, X., Li, J., Zhu, L., Pang, R., & Zhang, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1348844 · Cited by 26
Immunotherapy for Parkinson’s Disease and Alzheimer’s Disease: A Promising Disease-Modifying Therapy
Mahboob, A., Ali, H., Naimi, A. J. A., Yousef, M., Rob, M., Al-Muhannadi, N. A., Senevirathne, D. K. L., & Châari, A. (2024) · Cells · doi:10.3390/cells13181527 · Cited by 26
Carriel, J. M., Nájera, H., Samper-Herrero, A., Živković, S., Martínez‐Esteso, M. J., Martínez‐Márquez, A., Sellés‐Marchart, S., Obrebska, A. A., & Bru‐Martínez, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313036 · Cited by 25
Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review
Ali, N., Sayeed, U., Shahid, S. M. A., Akhtar, S., & Khan, M. K. A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10463-w · Cited by 26
Systems Human Immunology and AI: Immune Setpoint and Immune Health
Lei, Y., & Tsang, J. S. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-042631 · Cited by 27
Relation of CDC42 , Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease
Zhang, Y., & Niu, C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51643 · Cited by 27
The Eye as a Diagnostic Tool for Alzheimer’s Disease
Hussain, A., Sheikh, Z., & Subramanian, M. L. (2023) · Life · doi:10.3390/life13030726 · Cited by 27
Adelson, R. P., Garikipati, A., Maharjan, J., Ciobanu, M., Barnes, G., Singh, N. P., Dinenno, F. A., Mao, Q., & Das, R. (2023) · Diagnostics · doi:10.3390/diagnostics14010013 · Cited by 24
Wiefels, M. D., Furar, E., Eshraghi, R. S., Mittal, J., Memis, I., Moosa, M., Mittal, R., & Eshraghi, A. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221003085508 · Cited by 25
Páez, A., Frimpong, E., Mograss, M., & Dang‐Vu, T. T. (2024) · Journal of Sleep Research · doi:10.1111/jsr.14189 · Cited by 24
Li, K., Wu, J., Mei, Y., Zhao, J., Zhou, Q., Li, Y., Yang, M., Xu, J., Zhao, M., & Xu, Q. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.140049 · Cited by 23
Yang, Y., Wei, S., Tian, H., Cheng, J., Zhong, Y., Zhong, X., Huang, D., Jiang, C., & Ke, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1439115 · Cited by 24
Aresta, A. M., Vietro, N. D., & Zambonin, C. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084490 · Cited by 22
Wang, J., Lu, X., & He, Y. (2025) · Biosensors · doi:10.3390/bios15020085 · Cited by 24
Magagnoli, J., Ambati, M., Cummings, T. H., Nguyen, J. D. K., Thomas, C. C., Ambati, V. L., Sutton, S. S., Gelfand, B. D., & Ambati, J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70180 · Cited by 22
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 23
Bykova, M., Hou, Y., Eng, C., & Cheng, F. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac208 · Cited by 24
Quang-Bao, L., Baecker, D., Dung, D. T. M., Nhung, N. P., Thuần, N. T. D., Nguyen, P. L., Dung, P. T. P., Hương, T. T. L., Rasulev, B., Casañola‐Martín, G. M., et al. (2023) · Molecules · doi:10.3390/molecules28083588 · Cited by 23
Biomarkers and Cognition Study, Singapore (BIOCIS): Protocol, Study Design, and Preliminary Findings
Leow, Y. J., Wang, J. D. J., Vipin, A., Sandhu, G. K., Soo, S. A., Kumar, D., Mohammed, A. A., Zailan, F. Z., Lee, F. P. H. E., Ghildiyal, S., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.89 · Cited by 22
Mulumba, J., Duan, R., Luo, B., Wu, J., Sulaiman, M., Wang, F., & Yang, Y. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100675 · Cited by 23
Arora, P., Swati, Rani, S., Jha, S., Gupta, S., & Kumar, S. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11170-1 · Cited by 23
Wtpsk, S., Oikari, L. E., Bharadwaj, P., Jayasena, V., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Nutrients · doi:10.3390/nu17142286 · Cited by 23
Papatsimpas, V., Vrouva, S., Papathanasiou, G., Papadopoulou, Μ., Bouzineki, C., Kanellopoulou, S., Moutafi, D., & Bakalidou, D. (2023) · Brain Sciences · doi:10.3390/brainsci13071112 · Cited by 25
Yadav, V. K., Choudhary, N., Gacem, A., Verma, R. K., Hasan, M. A., Imam, M. T., Almalki, Z. S., Yadav, K. K., Park, H.-K., Ghosh, T., et al. (2023) · Redox Report · doi:10.1080/13510002.2023.2269331 · Cited by 22
NMR-based metabolomics in Alzheimer’s disease research: a review
Vignoli, A., & Tenori, L. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1308500 · Cited by 22
Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans
Hansen, B., Roomp, K., Ebid, H. H., & Schneider, J. G. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100197 · Cited by 21
Bortty, J. C., Chakraborty, G. S., Noman, I. R., Batra, S., Das, J., Bishnu, K. K., Tarafder, M. T. R., & Islam, A. (2025) · Diagnostics · doi:10.3390/diagnostics15060789 · Cited by 21
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Seplovich, G., Bouchi, Y., Vaccari, J. P. D. R., Pareja, J. C. M., Reisner, A., Blackwell, L. S., Mechref, Y. S., Wang, K., Tyndall, J. A., Tharakan, B., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00107 · Cited by 21
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer’s disease
Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Saad, . M., Al-Gareeb, A. I., & Albuhadily, A. K. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01796-w · Cited by 20
Katariya, R., Sammeta, S. S., Kale, M. B., Kotagale, N. R., Umekar, M. J., & Taksande, B. G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102269 · Cited by 20
Liu, L., Gracely, E. J., Zhao, X., Gliebus, G. P., May, N. S., Volpe, S. L., Shi, J., DiMaria-Ghalili, R. A., & Eisen, H. J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1361772 · Cited by 20
Recent progress in engineered extracellular vesicles and their biomedical applications
Mazahir, F., & Yadav, A. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122747 · Cited by 21
Liu, T., Wang, S., Zhang, Y., Li, Y., Liu, Y., & Huang, S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01589 · Cited by 20
Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies
Jamal, R., Shaikh, M. A., Taleuzzaman, M., Haque, Z., Albratty, M., Alam, M. S., Makeen, H. A., Zoghebi, K. A., & Saleh, S. F. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251330500 · Cited by 19
Cerium-based nanoparticles for neurodegeneration: emerging redox therapeutics beyond pharmaceuticals
Mishra, K., Tripathi, S., Tiwari, A. K., Rana, R., Yadav, P., & Chourasia, M. K. (2025) · RSC Advances · doi:10.1039/d5ra03599f · Cited by 20
Singh, S. A., & Vellapandian, C. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00478-0 · Cited by 19
Ponsoda, J. M., Beleña, M. Á., & Díaz, A. (2023) · Healthcare · doi:10.3390/healthcare11233084 · Cited by 19
Current status of PET tracers for the early diagnosis of Alzheimer's disease
Li, Y., Liu, T., Zeng, Q., & Cui, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117546 · Cited by 20
Metadata
- Authors
- Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q.
- Affiliations
- Eisai (United States) (US)
- Venue
- Neurology and Therapy
- Published
- 2022-03-14
- Volume
- 11
- Issue
- 2
- Pages
- 553-569
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- PMC
- PMC9095793
- OpenAlex
- W4221041873
- Cited by
- 629
- References
- 74
- Citations by year
- 2026: 161 · 2025: 208 · 2024: 161 · 2023: 80 · 2022: 19
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neurology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Eisai
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, clinical progression, mild cognitive impairment, amyloid-beta deposition, neurodegeneration, preclinical Alzheimer's disease, disease risk factors, APOE ε4, white matter hyperintensities, entorhinal cortex atrophy, cerebrospinal fluid biomarkers, tau protein, neurogranin, dementia mortality, underdiagnosis, disease-modifying therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
